Task: Answer the multiple-choice question.
Query: Which compound exhibits a 8.045% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(C)nc(SCC(=O)N/N=C/c2ccc3c(c2)OCO3)n1
b: COc1cc(OC)nc(Oc2cc(/C=N/O)ccc2OC)n1
Answer: a. Cc1cc(C)nc(SCC(=O)N/N=C/c2ccc3c(c2)OCO3)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)nc(SCC(=O)N/N=C/c2ccc3c(c2)OCO3)n1
Cc1cc(C)nc(SCC(=O)N/N=C/c2ccc3c(c2)OCO3)n1
N-[(E)-1,3-benzodioxol-5-ylmethylideneamino]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide